• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重支气管扩张剂治疗稳定期慢性阻塞性肺疾病患者健康状况管理的研究

Study on the Management of the Health Status of Patients with Stable Chronic Obstructive Pulmonary Disease Treated with Double Bronchodilator.

作者信息

Wang Wei, Yang Qing, Xun Qiufen, Ye Xiaoqun

机构信息

Department of Respiratory, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.

出版信息

Evid Based Complement Alternat Med. 2022 Jul 9;2022:1183436. doi: 10.1155/2022/1183436. eCollection 2022.

DOI:10.1155/2022/1183436
PMID:35855824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9288299/
Abstract

OBJECTIVE

To investigate the patients with stable chronic obstructive pulmonary disease (COPD) to understand the use of double bronchodilator therapy and influencing factors.

METHODS

The patients with stable COPD who used double bronchodilators were continuously enrolled in our hospital. The information of demographic characteristics, medical history, physical examination, drug use, and correct treatment methods after using inhaled drugs were collected by standardized questionnaire. Measurement data between groups were compared by using the independent sample -test, and counting data between groups were compared by using the chi-square test.

RESULTS

A total of 102 patients were included in the analysis. The proportion of patients with stable COPD who correctly used dual bronchodilators was 59.8% (61 patients). In the GOLD classification, the correct use rate of C-level patients was 69.8%, which was significantly higher than the used correct rate of D-level patients (49.0%) (=0.032). In the age group, the correct use rate of patients <65 years old was 72.1%, which was significantly higher than that of patients ≥65 years old (50.8%) (=0.031). In addition, education level, duration of drug use, and drug type may also affect the correct use of drugs, but no significant statistical significance was found between the groups of these three factors ( > 0.05).

CONCLUSION

There is still a gap between the treatment of dual bronchodilators in patients with stable COPD and the guidelines, so the management of COPD should be strengthened. Besides, the correct use rate could be affected by the GOLD classification and age.

摘要

目的

调查稳定期慢性阻塞性肺疾病(COPD)患者,以了解双支气管扩张剂治疗的使用情况及影响因素。

方法

连续纳入我院使用双支气管扩张剂的稳定期COPD患者。通过标准化问卷收集人口统计学特征、病史、体格检查、用药情况以及吸入药物后正确治疗方法的信息。组间计量资料比较采用独立样本t检验,组间计数资料比较采用卡方检验。

结果

共纳入102例患者进行分析。稳定期COPD患者正确使用双支气管扩张剂的比例为59.8%(61例)。在GOLD分级中,C级患者的正确使用率为69.8%,显著高于D级患者的正确使用率(49.0%)(P = 0.032)。在年龄组中,<65岁患者的正确使用率为72.1%,显著高于≥65岁患者(50.8%)(P = 0.031)。此外,教育程度、用药时长和药物类型可能也会影响药物的正确使用,但这三个因素组间比较差异均无统计学意义(P>0.05)。

结论

稳定期COPD患者双支气管扩张剂治疗与指南之间仍存在差距,因此应加强COPD的管理。此外,正确使用率可能受GOLD分级和年龄的影响。

相似文献

1
Study on the Management of the Health Status of Patients with Stable Chronic Obstructive Pulmonary Disease Treated with Double Bronchodilator.双重支气管扩张剂治疗稳定期慢性阻塞性肺疾病患者健康状况管理的研究
Evid Based Complement Alternat Med. 2022 Jul 9;2022:1183436. doi: 10.1155/2022/1183436. eCollection 2022.
2
Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.慢性阻塞性肺疾病 - 稳定期疾病的诊断和管理;基于临床表型的可治疗特征概念,采用个体化护理方法。捷克肺病和结核学会立场文件。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Dec;164(4):325-356. doi: 10.5507/bp.2020.056.
3
Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.长效支气管扩张剂或吸入性皮质类固醇联合治疗的 COPD 患者对当前指南的依从性。
Int J Chron Obstruct Pulmon Dis. 2012;7:201-9. doi: 10.2147/COPD.S25805. Epub 2012 Mar 15.
4
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis.乌美溴铵/维兰特罗与其他支气管扩张剂治疗慢性阻塞性肺疾病的疗效比较:一项网络荟萃分析。
Adv Ther. 2022 Nov;39(11):4961-5010. doi: 10.1007/s12325-022-02234-x. Epub 2022 Jul 20.
5
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
6
Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.药物治疗依从性的差异与慢性阻塞性肺疾病全球倡议(GOLD):回顾性 actuarial 理赔数据分析。
Curr Med Res Opin. 2011 Jul;27(7):1425-9. doi: 10.1185/03007995.2011.583230. Epub 2011 May 23.
7
Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.慢性阻塞性肺疾病(COPD)管理指南:2004年修订版
S Afr Med J. 2004 Jul;94(7 Pt 2):559-75.
8
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.慢性阻塞性肺疾病稳定期的诊断与管理:美国医师学会、美国胸科学会、美国胸科学会和欧洲呼吸学会的临床实践指南更新。
Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.
9
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials.噻托溴铵/奥达特罗对比噻托溴铵作为 COPD 患者一线维持治疗的疗效:四项临床试验的汇总分析,这些患者对 LAMA、LABA 和 ICS 均为初治。
Adv Ther. 2020 Oct;37(10):4175-4189. doi: 10.1007/s12325-020-01411-0. Epub 2020 Jul 15.
10
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.用于稳定期慢性阻塞性肺疾病的短效β2受体激动剂
Cochrane Database Syst Rev. 2002(4):CD001495. doi: 10.1002/14651858.CD001495.

引用本文的文献

1
Retracted: Study on the Management of the Health Status of Patients with Stable Chronic Obstructive Pulmonary Disease Treated with Double Bronchodilator.撤回:关于使用双支气管扩张剂治疗稳定期慢性阻塞性肺疾病患者健康状况管理的研究。
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9879741. doi: 10.1155/2023/9879741. eCollection 2023.
2
Treatment patterns in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的治疗模式:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231158283. doi: 10.1177/17534666231158283.

本文引用的文献

1
COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences.亚太地区慢性阻塞性肺疾病指南:异同点
Diagnostics (Basel). 2021 Jun 24;11(7):1153. doi: 10.3390/diagnostics11071153.
2
Pharmacological treatment of stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病的药物治疗。
Respirology. 2021 Jul;26(7):643-651. doi: 10.1111/resp.14046. Epub 2021 Apr 7.
3
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.
4
Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review.中低收入国家 COPD 指南中的差距:系统范围综述。
Chest. 2021 Feb;159(2):575-584. doi: 10.1016/j.chest.2020.09.260. Epub 2020 Oct 8.
5
Dual use of bronchodilators versus monotherapy, and its impact on pulmonary rehabilitation in COPD patients.支气管扩张剂联合使用与单一疗法及其对慢性阻塞性肺疾病(COPD)患者肺康复的影响。
Pulm Pharmacol Ther. 2020 Apr;61:101898. doi: 10.1016/j.pupt.2020.101898. Epub 2020 Jan 21.
6
Update on management of stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病的管理进展
J Thorac Dis. 2019 Sep;11(Suppl 14):S1800-S1809. doi: 10.21037/jtd.2019.06.12.
7
Prediction models for the development of COPD: a systematic review.慢性阻塞性肺疾病(COPD)发生发展的预测模型:一项系统综述
Int J Chron Obstruct Pulmon Dis. 2018 Jun 14;13:1927-1935. doi: 10.2147/COPD.S155675. eCollection 2018.
8
Prevalence of chronic obstructive pulmonary disease (COPD) in China in 1990 and 2010.1990年和2010年中国慢性阻塞性肺疾病(COPD)的患病率。
J Glob Health. 2017 Dec;7(2):020704. doi: 10.7189/jogh.07.020704.
9
The 2017 Global Initiative for Chronic Obstructive Lung Disease Report and Practice Implications for the Respiratory Therapist.《2017年慢性阻塞性肺疾病全球倡议报告及对呼吸治疗师的实践意义》
Respir Care. 2017 Nov;62(11):1492-1500. doi: 10.4187/respcare.05402. Epub 2017 Sep 5.
10
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.